People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s Wegovy.

Let's consider two corporations that could help you do better than average in the next decade: Eli Lilly (NYSE: LLY) and ...

Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions in body weight and waist circumference.

OMAHA, Neb. (WOWT) - The FDA is cracking down on off brand weight loss products similar to Ozempic. GLP-1 drugs for weight loss like Wegovy or Zepbound were previously in a shortage.

The Food and Drug Administration is cracking down on copycat versions of Ozempic — the brand name of semaglutide — and ...

Cigna subsidiary Evernorth Health Services will automate prior authorizations for GLP-1 weight-loss drugs under a new program ...

Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly.

Zepbound outperformed Nordisk's Wegovy in terms of weight loss, solidifying Lilly's leadership in the anti-obesity drug ...

With the active ingredients in drugs like Ozempic and Zepbound no longer in shortage ... of vials but doesn’t know what he’s going to do when he runs out. “I’m extremely nervous about ...

How does a blind guy know if he looks cool? #shorts Posted: May 13, 2025 | Last updated: May 13, 2025 The LA Times sent out photographer Al Shavin to take pics for a story written by Jackie Snow ...

Women typically lose more weight on Zepbound and Wegovy than men do. Doctors will probably want to consider detailed results on how the two medicines compare across different types of patients ...

A new study published in the New England Journal of Medicine comparing Eli Lilly’s Zepbound to Novo Nordisk ... you definitely want to do it with someone who has the expertise and how to ...